Hledání článků
Filtry
Harcourt BE, Sourris KC, Coughlan MT, et al. Targeted reduction of advance glycation improves renal function in obesity. Kidney Int 2011, 80:190–198.
Jouret F, et al. Positron‑emission computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2011; 6:1644–1650.
Cejka D, Jager‑Lansky A, Kieweg H, et al. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transplant 2011 May 25. [Epub ahead of print]
Cejka D, Herberth J, Branscum AJ, et al. Sclerostin and Dickkopf‑1 in renal osteodystrophy. Clin J Am Soc Nephrol 2011;6:877–882.
Molnar MZ, Mehrotra R, Duong U, Kovesdy CP, Kalantar‑Zadeh K. Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol 2011;6:1973–1981.
Tang SCW, Lin M, Tam S et al. Aliskiren combined with losartan in immunoglobulin A nephropathy: an open‑labeled pilot study. Nephrol Dial Transplant 2011;26:1976–1983.
Sayyed SG, Ryu M, Kulkarni OP, et al. An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int 2011;80:68–78.
Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J, Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med 2011;37:241–248.
Pergola PE, Raskin P, Toto RD, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 2011;365:327–336.
Baigent C, Landray MJ, Reith C, et al., on behalf of the SHARP investigators. The effect of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo‑controlled trial. Lancet 2011, 377:2181–2192.
SHARP Collaborative Group: Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low‑density lipoprotein cholesterol among 9 438 patients with chronic kidney disease. Am Heart J 2010;160:785–794.
Gansevoort RT, Matsushita K.,van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J and Chronic Kidney Disease Prognosis Consortium. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta‑analysis of general and high‑risk population cohorts. Kidney Int 2011;80:93–104.
Manno C, Bonifati C, Torres DD, Campobasso N, Schena FP. Desmopressin acetate in percutaneous ultrasound – guided kidney biopsy: A randomized controlled trial. Am J Kindey Dis 2011;57:850–855.
Herrmann SMS, Gertz MA, Stegall MD, et al. Long‑term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant 2011;26:2032–2036.
Nogueira EL, Costa AC, Santana A, Querna JO, Silva S, Mil‑Homens C, Costa AG. Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyreoidectomized patients: a series of five case reports. Transplantation 2011;92:316–320.